Zobrazeno 1 - 1
of 1
pro vyhledávání: '"HvdL Gythfeldt"'
Autor:
Ellen Schlichting, Bjørn Naume, TG Lien, Elin Borgen, Anne Lise Børresen-Dale, OC Lindgjærde, HvdL Gythfeldt, Øystein Garred, Olav Engebråten, Laxmi Silwal-Pandit, Erik Wist
Publikováno v:
Cancer Research. 79:P6-07
Background: Bevacizumab added to conventional neoadjuvant chemotherapy increase the proportion of patients achieving a pathological complete response (pCR). Identifying patients responding to antiangiogenic therapy have been challenging. The primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08dbe04407cc2ebd6086107014628f51
https://doi.org/10.1158/1538-7445.sabcs18-p6-07-01
https://doi.org/10.1158/1538-7445.sabcs18-p6-07-01
